Boyun new materials: it is planned to transfer part of the equity of Honeywell Boyun aviation system (Hunan) through agreement

GlaxoSmithKline in China: Challenges Faced

China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.

Ninebot Achieved Revenue of Over CNY 4.8 Bn in H1 2022, E-bike Revenue Increased 81% YoY

Ninebot's semi-annual report shows an 81% year-on-year increase in revenue from e-bike, with the advantages of cultivating its own brand coming to the fore.

Ecommerce SaaS Provider Dianxiaomi Bags USD 110 Million in Series D

Amid the boom of the digital economy, Dianxiaomi hopes to facilitate Chinese brands to go global and empower international brands to lead the world with its SaaS management system as the driver.

Naxi Technology Completed Angel Round of Financing

Naxi Technology, a developer of optical microscopic imaging equipment, will continue to develop groundbreaking microscopic technologies and products with the fresh proceeds.

Gilead Reached USD 455 Mn Contract with Everest for Asian Rights

The company said it would use the money to fund additional dealmaking activities, clinical development of Calliditas Therapeutics-partnered kidney disease drug Nefecon in several Asia countries and other pipeline assets.